Literature DB >> 16281585

[Thromboangiitis obliterans: an overview].

Daniela Hoeft1, Knut Kroger, Stephan Grabbe, Joachim Dissemond.   

Abstract

Thromboangiitis obliterans is a vascular disease characterized by a segmental, non-atherosclerotic inflammation of the small and medium-sized arteries and veins. The vascular changes are mainly found on the distal extremities. Involvement of visceral organs is rare. Affected patients are mostly young male smokers, who develop ulcers and gangrene of the toes and fingers as a result of the vascular ischaemia. Diagnosis is made using characteristic clinical criteria as well as pathological findings in arteriography and histopathology. Although the exact underlying causes of Buerger's disease are still unknown, the disease is strongly associated with tobacco smoking. Although most investigators speculate about an autoimmune mechanism, no causative antigens have yet been discovered. The only definite form of therapy is the discontinuation of tobacco use. On the basis of smoking cessation, further therapies (e.g. administration of prostacyclin analoga) are possible. The mortality rate for patients with Buerger's disease is not higher than that for the rest of the adult population, but patients often require minor and major limb amputation due to ulcerations.

Entities:  

Mesh:

Year:  2004        PMID: 16281585     DOI: 10.1046/j.1439-0353.2004.04047.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  2 in total

1.  Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practices.

Authors:  Edwaldo Edner Joviliano; Renata Dellalibera-Joviliano; Marcelo Dalio; Paulo Rb Evora; Carlos E Piccinato
Journal:  Int J Angiol       Date:  2009

2.  Tobacco and bone fractures: A review of the facts and issues that every orthopaedic surgeon should know.

Authors:  J Hernigou; F Schuind
Journal:  Bone Joint Res       Date:  2019-07-05       Impact factor: 5.853

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.